Literature DB >> 12966600

Determinants of discordance between patients and physicians in their assessment of lupus disease activity.

Jim C Yen1, Michal Abrahamowicz, Patricia L Dobkin, Ann E Clarke, Renaldo N Battista, Paul R Fortin.   

Abstract

OBJECTIVE: We evaluated different methods for quantifying patient-physician discordance and identified factors associated with discordance in the assessment of lupus disease activity.
METHODS: Data from 208 female patients who had a comprehensive annual examination were extracted from the Montreal General Hospital Lupus Registry. Discordance was measured by the difference between the patient self-reported 10 cm visual analog scale (VAS) and the physician VAS for global disease activity (VASDIFF). Multiple linear regression was used to identify the correlates of discordance, e.g., SF-36TM scales, Systemic Lupus Activity Measure (SLAM) components, etc. Four regression models were estimated using: (1) all patients; (2) only patients who evaluated disease activity higher than their physician's assessment; (3) only patients who evaluated disease activity lower than their physician's assessment; and (4) all patients, with the absolute value of VASDIFF as the dependent variable.
RESULTS: Of the 208 observations, 150 (72%) of the VASDIFF scores were within +/- 2.5 cm on a 10 cm scale, indicating absence of marked discordance; 43 (20.7%) were from patients overscoring and 15 (7.2%) from patients underscoring their physician by at least 2.5 cm. Higher SF-36 role physical score, more bodily pain, and lower role emotional score in addition to the SLAM-skin component were independently associated with higher discordance. SF-36 social function and mental health scores as well as SLAM-neurological and kidney components were correlated with discordance in some subanalyses. Bodily pain was the most important variable for predicting "clinically relevant" discordance, followed by SLAM-skin and kidney components.
CONCLUSION: Discordance between patients and physicians may result from patients scoring their disease activity based on their psychological and physical well-being, whereas physicians score disease activity based on the clinical and physical signs and symptoms of lupus.

Entities:  

Mesh:

Year:  2003        PMID: 12966600

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  32 in total

1.  Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

Authors:  Jennifer L Barton; John Imboden; Jonathan Graf; David Glidden; Edward H Yelin; Dean Schillinger
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

2.  A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians.

Authors:  Nicolino Ruperto; Luigi Carozzino; Roberto Jamone; Federico Freschi; Gianfranco Picollo; Marcella Zera; Ornella Della Casa Alberighi; Enrica Salvatori; Alessandra Del Vecchio; Paolo Dionisio; Alberto Martini
Journal:  Ital J Pediatr       Date:  2011-09-29       Impact factor: 2.638

3.  Level of patient-physician agreement in assessment of change following conservative rehabilitation for shoulder pain.

Authors:  Stephanie D Moore-Reed; W Ben Kibler; Heather Bush; Tim L Uhl
Journal:  Shoulder Elbow       Date:  2016-07-15

4.  Doctors' versus patients' global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials.

Authors:  Evangelos Evangelou; Georgios Tsianos; John P A Ioannidis
Journal:  BMJ       Date:  2008-05-21

5.  [Possibilities and limits of patient-reported outcome exemplified by systemic lupus erythematosus and the LuLa study].

Authors:  G Chehab; J Richter; M Schneider
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

6.  Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physicians.

Authors:  David J Coman; Ian M Hayes; Veronica Collins; Margaret Sahhar; J Ed Wraith; Martin B Delatycki
Journal:  JIMD Rep       Date:  2011-06-22

7.  Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity.

Authors:  Nasim A Khan; Horace J Spencer; Esam Abda; Amita Aggarwal; Rieke Alten; Codrina Ancuta; Daina Andersone; Martin Bergman; Jurgen Craig-Muller; Jacqueline Detert; Lia Georgescu; Laure Gossec; Hisham Hamoud; Johannes W G Jacobs; Ieda Maria Magalhaes Laurindo; Maria Majdan; Antonio Naranjo; Sapan Pandya; Christof Pohl; Georg Schett; Zahraa I Selim; Sergio Toloza; Hisahi Yamanaka; Tuulikki Sokka
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-02       Impact factor: 4.794

8.  Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

Authors:  X Ng; S dosReis; R Beardsley; L Magder; C D Mullins; M Petri
Journal:  Lupus       Date:  2017-08-31       Impact factor: 2.911

9.  Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.

Authors:  Benjamin Chaigne; Axel Finckh; Deshire Alpizar-Rodriguez; Delphine Courvoisier; Camillo Ribi; Carlo Chizzolini
Journal:  Qual Life Res       Date:  2017-03-11       Impact factor: 4.147

10.  Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus.

Authors:  A M Eudy; A I Vines; M A Dooley; G S Cooper; C G Parks
Journal:  Lupus       Date:  2014-07-23       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.